SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...

Myriad Genetics, Inc. has launched a new educational ... pregnant women between 7-37 weeks gestational age. In a 2021 laboratory test, SneakPeek accurately determined fetal sex in 99.02% of ...

Myriad offers three genetic tests to those who are pregnant ... women between 7-37 weeks gestational age. In a 2021 laboratory test, SneakPeek accurately determined fetal sex in 99.02% of ...

Its Labs of the Future initiative has resulted ... to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease ...

Myriad Genetics , Inc. (NASDAQ:MYGN) stock has reached a new 52-week low, touching down at $12.16, as the company faces a challenging market environment. According to InvestingPro data, technical ...

Myriad continues to position itself as a leader in genetic testing and precision medicine ... assays and its Labs of the Future initiative, which aims to enhance efficiency and reduce operating ...